• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部复发性鼻咽癌的治疗

Treatment of locally recurrent carcinoma of the nasopharynx.

作者信息

Fu K K, Newman H, Phillips T L

出版信息

Radiology. 1975 Nov;117(2):425-31. doi: 10.1148/117.2.425.

DOI:10.1148/117.2.425
PMID:170644
Abstract

Forty-two patients with recurrent nasopharyngeal carcinoma in the primary site and/or neck nodes were treated at the University of California, San Francisco, between 1940 and 1974. Sixty-nine per cent of the recurrences appeared within 3 years and 83% within 5 years after initial treatment. Retreatment included external radiotherapy and/or intercavitary radium or cobalt beads in the majority of cases. The actuarial survival rate was 41% at 5 years after first recurrence. Survival rates increased proportionally with increasing time between initial treatment and recurrence. There was no statistically significant difference in survival rates with respect to age, sex, race, or histology. Local soft-tissue or bone necrosis developed in 9 patients, but both conditions were tolerated well.

摘要

1940年至1974年间,加利福尼亚大学旧金山分校对42例原发部位和/或颈部淋巴结复发的鼻咽癌患者进行了治疗。69%的复发发生在初次治疗后的3年内,83%发生在5年内。在大多数病例中,再次治疗包括外照射放疗和/或腔内镭或钴珠植入。首次复发后5年的精算生存率为41%。生存率随着初次治疗与复发之间时间的增加而成比例提高。在年龄、性别、种族或组织学方面,生存率没有统计学上的显著差异。9例患者出现了局部软组织或骨坏死,但这两种情况均耐受性良好。

相似文献

1
Treatment of locally recurrent carcinoma of the nasopharynx.局部复发性鼻咽癌的治疗
Radiology. 1975 Nov;117(2):425-31. doi: 10.1148/117.2.425.
2
Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.局部复发性鼻咽癌再治疗的结果及预后因素
Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1099-111. doi: 10.1016/s0360-3016(98)00164-3.
3
Management of locally recurrent carcinoma of the nasopharynx.鼻咽癌局部复发的治疗
Radiology. 1966 May;86(5):900-3. doi: 10.1148/86.5.900.
4
Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.II期鼻咽癌同步推量放疗的前瞻性II期试验。
Oral Oncol. 2008 Jul;44(7):703-9. doi: 10.1016/j.oraloncology.2007.09.005. Epub 2007 Dec 3.
5
Prognostic factors for loco-regional control and outcome of re-irradiation for patients with poorly-differentiated squamous cell carcinoma of the nasopharynx.
Jpn J Clin Oncol. 1995 Jun;25(3):72-8.
6
[Lymphoepithelial carcinoma of the nasopharynx: the treatment results following radiotherapy].
Strahlenther Onkol. 1986 Nov;162(11):698-703.
7
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.调强放射治疗复发性鼻咽癌的初步经验。
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):682-7. doi: 10.1016/S0360-3016(03)01508-6.
8
[Re-radiation of recurrent nasopharyngeal carcinoma--analysis of 58 cases].[复发性鼻咽癌再程放疗——58例分析]
Zhonghua Zhong Liu Za Zhi. 1989 Jul;11(4):288-90.
9
Nasopharyngeal carcinoma: treatment results with primary radiation therapy.鼻咽癌:原发性放射治疗的治疗结果
Laryngoscope. 1992 Sep;102(9):965-72. doi: 10.1288/00005537-199209000-00002.
10
Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.局部复发性鼻咽癌的再程放疗:治疗结果及预后因素
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):388-94. doi: 10.1016/j.ijrobp.2004.03.021.

引用本文的文献

1
Aggressive Treatment Including Endonasal Surgical Sequestrectomy with Vascularized Nasoseptal Flap Can Improve Outcomes of Skull Base Osteoradionecrosis.包括采用带血管鼻中隔瓣的鼻内镜手术死骨切除术在内的积极治疗可改善颅底放射性骨坏死的治疗效果。
J Neurol Surg B Skull Base. 2021 Jan 14;83(Suppl 2):e15-e23. doi: 10.1055/s-0040-1722669. eCollection 2022 Jun.
2
Osteoradionecrosis of the skull base.颅底放射性骨坏死
J Neurooncol. 2020 Dec;150(3):477-482. doi: 10.1007/s11060-020-03462-3. Epub 2020 May 11.
3
Preserving the legacy of reirradiation: A narrative review of historical publications.
保留再照射的历史遗产:对历史出版物的叙述性综述
Adv Radiat Oncol. 2017 Feb 28;2(2):176-182. doi: 10.1016/j.adro.2017.02.005. eCollection 2017 Apr-Jun.